Skip to main content

Table 1 Comparison of basic information between the two groups

From: Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients

Parameter

Observation Group

(n = 43)

Control Group

(n = 43)

χ2/Z/t

P value

Age (years)

54.74 ± 5.77

54.85 ± 5.84

0.085

0.932

Gender (male)

20 (46.51%)

22 (52.38%)

0.105

0.746

Body Mass Index (kg/m2)

22.37 ± 1.08

21.92 ± 1.03

1.966

0.053

Onset Time (days)

4.39 ± 0.66

4.53 ± 0.14

1.406

0.166

Affected Limb (left lower limb/right lower limb)

30 (69.77%) /

13 (30.23%)

28 (66.67%) /

14 (33.33%)

0.005

0.941

Balloon Diameter (mm)

    

- Iliac vein

10.8 ± 1.2

10.5 ± 1.1

1.20

0.342

- Common femoral vein

8.6 ± 0.9

8.4 ± 0.8

1.08

0.415

- Superficial femoral vein

6.9 ± 0.7

7.1 ± 0.6

-1.11

0.278

Stent Placement Rate

4 (9.3%)

5 (11.9%)

0.16

0.682